ONTARGET Study of Telmisartan, Ramipril, or Both in High-Risk Patients

Curr Hypertens Rep. 2008 Oct;10(5):345-8. doi: 10.1007/s11906-008-0065-3.
No abstract available

Publication types

  • Comment